October 25, 2012 — Immuneering’s CEO (Ben Zeskind, PhD, MBA) will moderate a plenary session at the 4th Translational Medicine Conference, and give a talk entitled “Predicting Response and Understanding…
Read More
October 25, 2012 — Immuneering’s CEO (Ben Zeskind, PhD, MBA) will moderate a plenary session at the 4th Translational Medicine Conference, and give a talk entitled “Predicting Response and Understanding…